Newest Clinical Trial in COVID-19 : Lopinavir-Ritonavir and Favipiravin
Update: 2020-03-26
Description
Untuk membahas bukti ilmiah mengenai pilihan terapi farmakologi pada pneumonia yang diakibatkan oleh coronavirus, Cochrane Indonesia di UGM bekerjasama dengan MMR /PKMK FK-KMK UGM menyelenggarakan webinar dengan judul Newest Clinical Trial in COVID-19 yang membahas 2 artikel yaitu:
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 - Oleh dr. Jarir At Thobari, DPharm, PhD
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study - Oleh dr. Yudha Nur Patria, DCH, M.Med (Clin Epi), M.M.S, PhD
Moderator : dr. Dhite Bayu Nugroho, MSc, PhD
Kamis, 26 Maret 2020
Pukul 12.30 - 14.30
Link Webinar :
https://attendee.gotowebinar.com/register/3317958161934381325
Webinar ID : 243-591-459
Alternatif livestreaming (Youtube)
https://www.youtube.com/c/unitpublikasi/live
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 - Oleh dr. Jarir At Thobari, DPharm, PhD
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study - Oleh dr. Yudha Nur Patria, DCH, M.Med (Clin Epi), M.M.S, PhD
Moderator : dr. Dhite Bayu Nugroho, MSc, PhD
Kamis, 26 Maret 2020
Pukul 12.30 - 14.30
Link Webinar :
https://attendee.gotowebinar.com/register/3317958161934381325
Webinar ID : 243-591-459
Alternatif livestreaming (Youtube)
https://www.youtube.com/c/unitpublikasi/live
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
